Rachel Lutz

TB therapy is a new risk factor for recurrent C diff

Treatment with rifampin shows it can increase the chances for recurrent Clostridium difficile (C diff) infection according to investigators in Mexico.

Read More →

TB antibacterial courses ineffective in minimizing antibiotic use

The current trials testing broad-spectrum antibiotics before treating tuberculosis are not aligned with protocols designed to minimize the use of antibiotics, according to a paper published in The Lancet Infectious Diseases.

Read More →

Page 1 of 1 · Total posts: 2